Ekso Bionics Holdings Inc reports results for the quarter ended in March - Earnings Summary

Chronoscale

30/04/2021 03:31

* Ekso Bionics Holdings Inc  EKSO.OQ  reported a quarterly
adjusted loss of 34 cents​​ per share for the quarter ended
in March. The lone analyst forecast for the quarter was for a
loss of 24 cents per share.
* Revenue rose 30.1% to $1.91 million from a year ago​; 
analysts expected $3.00 million.
* Ekso Bionics Holdings Inc's reported EPS for the quarter was a
loss of 34 cents​.
* The mean earnings estimate of analysts had risen by about 25%
in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Ekso Bionics Holdings Inc shares had fallen by 9.4% this
quarter and lost 8.8% so far this year.
* Wall Street's median 12-month price target for Ekso Bionics
Holdings Inc is $10.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated April 30 at 02:31 a.m. GMT.
​All figures in US Dollars.​